Brief: Innovative Pharmaceutical Biotech Says HY Loss Attributable HK$115.7 Mln
Nov 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* HY LOSS ATTRIBUTABLE HK$115.7 MILLION VERSUS PROFIT
HK$125.1
MILLION
* HY REVENUE HK$4.1 MILLION VERSUS HK$6.6 MILLION
Source text for Eikon: ID:nHKStM1RX
Further company coverage: 0399.HK
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU